506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)
NCT00684619
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
T-ALL, T-NHL (Lymphoblastic)
Interventions
DRUG:
Nelarabine
Sponsor
Goethe University